Shruti Bhat PhD, MBA, Operational Excellence Expert
  • Home
  • About Shruti
  • Books
  • Insights
  • Operational Excellence
  • Articles
    • Innovation Management and R&D Leadership
    • Product Development
    • Business Transformation
    • Process Improvement
    • Business Continuity
    • Change Management
    • Digital Transformation
    • Quality Improvement
  • Tools
    • Whitepapers
    • Checklists and Templates
    • Free eBook
    • Videos
  • Engage Shruti
    • Consulting >
      • Operational Excellence Consulting
      • Business Transformation Consulting
      • Innovation Management Consulting
    • Workshops
  • Case Studies
  • Blog
  • Contact

Drug Research and Technology Highlights

11/15/2009

0 Comments

 
Here are some updates on drug research and technology from my reading-

Internet usage to research drug information doubles among people in north America  -
Since 2005, the number of patients using the Internet to research prescription drug information has doubled to 102.3 million, according to a new study from Manhattan Research. In addition, health-related social media, in particular, has flourished in recent years with the increased popularity of online patient communities, social networking and health 2.0 applications.

Depomed Inc claims its extended-release form of gabapentin reduced post-shingles pain-
Depomed, Inc. Allegedly reported a successful late stage clinical trial of DM-1796, which is a drug intended to treat pain following the viral infection shingles. The company said that DM-1796 significantly reduced post-shingles pain compared to placebo after 10 weeks of treatment, and it plans to file for Food and Drug Administration approval by the end of March 2010. DM-1796 is an extended-release form of gabapentin, which is used to treat pain disorders and epilepsy.

Number of doctors using e-prescriptions will rise to more than double in 2010-
The number of physicians using electronic prescribing will have more than doubled in 2010,according to the e-prescribing network Surescripts. The company said more than 140,000 - 23 % of all office-based physicians, nurse practitioners and physician assistants in the United States  are E-prescribing today.  

EU approves sale of saxagliptin for diabetics-
Bristol-Myers Squibb Co. Press release stated that its new diabetes drug, Onglyza [saxagliptin], has been approved for sale in the European Union's 27 countries. Onglyza is expected to go on sale in the EU in this quarter, and was approved to be sold to improve blood sugar levels in combination with metformin, sulphonylurea or thiazolidinedione, when those drugs alone do not adequately control glycemic levels. 

Follow Shruti on Twitter, Facebook, YouTube, LinkedIn
0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Shruti Bhat, global leader in business turnaround, operational excellence and continuous improvement
    To contact Dr. Shruti Bhat text or WhatsApp at 1.403.969.6219

    New Book Released!

    Revolutionizing Industries with Lean Six Sigma

    Shruti's YouTube Channel ...

    Picture

    Blog Categories

    All
    3D Printing
    Agile
    Artificial Intelligence
    Automation
    Biotechnology
    Books
    Business Continuity
    Business Turnaround
    Case Studies
    Change Management
    Checklists
    Chemical Industry
    Continuous Improvement
    Design Thinking
    Digitalization
    Drug Delivery
    External News Links
    Hall Of Fame
    Healthcare
    Hoshin Kanri
    HR Development
    Innovation
    Insights
    ISO
    Just In Time
    Kaizen
    Leadership
    LEAN
    Lean Six Sigma
    Life Sciences
    Machine Learning
    Manufacturing
    Medical Devices
    Mistake Proofing
    Motivational Cards
    MSMEs
    Nanotechnology
    Operational Excellence
    Packaging
    Patents
    Personal Products
    Process Improvement
    Product Development
    Productivity Increase
    QbD
    Quality Management
    R&D Leadership
    Robotics
    Service Industry
    Six Sigma
    Strategy
    Supply Chain Logistics
    Telecom Industry
    Templates
    TQM
    Videos
    Voice Of Customer
    Whitepaper
    Workshops

    Shruti's books...

    Picture
    top ten strategic decision-making tools for operational excellence
    shruti bhat, business process management, continuous improvement
    kaizen for pharmaceutcials, medical devices and biotech industry book by Dr Shruti Bhat
    Book on Continuous improvement tools by Dr Shruti Bhat
    kaizen for leaders, continuous process improvement tool to increase profit and organizational excellence by shruti bhat
    kaizen, shruti bhat, continuous improvement, quality, operations management
    how to lead a successful business transformation
    leading organizations through crisis
    emotional intelligence
    how to overcome challenges of creating effective teams
    modular kaizen Vs Blitz kaizen
    How to increase employee engagement as a new boss

    ​Micro-Learning
    ​Partner

    Picture

    Wellness
    ​Partner

    Picture

Connect with Dr. Shruti Bhat at- ​Twitter, YouTube, LinkedIn​

© Copyright 1992- 2025 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions for details on this site usage.
Subscribe to Operational Excellence Academy YouTube Channel
​Subscribe to Operational Excellence Academy YouTube Channel
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media